OBJECTIVES: To determine the optimal iodine mass (IM) to achieve a 50-HU increase in hepatic attenuation for the detection of liver metastasis based on total body weight (TBW) or body surface area (BSA) at 80-kVp computed tomography (CT) imaging of the liver. METHODS:One-hundred and fifty patients who underwent contrast-enhanced CT at 80-kVp were randomised into three groups: 0.5 gI/kg, 0.4 gI/kg and 0.3 gI/kg. Portal venous phase images were evaluated for hepatic parenchymal enhancement (∆HU) and visualisation of liver metastasis. Iodine mass per BSA (gI/m(2)) calculated in individual patients were evaluated. RESULTS:Mean ∆HU for the 0.5 gI/kg group (84.2 HU) was higher than in the 0.4 gI/kg (66.1 HU) and 0.3 gI/kg (53.7 HU) groups (P < 0.001). Linear correlation equations between ∆HU and IM per TBW or BSA are ∆HU = 7.0 + 153.0 × IM/TBW (r = 0.73, P < 0.001) and ∆HU = 11.4 + 4.0 × IM/BSA (r = 0.75, P < 0.001), respectively. The three groups were comparable for the visualisation of hepatic metastases. CONCLUSIONS: The iodine mass to achieve a 50-HU increase in hepatic attenuation at 80-kVp CT was estimated to be 0.28 gI/kg of body weight or 9.6 gI/m(2) of body surface area. KEY POINTS: • Hepatic enhancement is expressed as ∆HU = 7.0 + 153.0 × IM [g]/TBW [kg]. • Hepatic enhancement is expressed as ∆HU = 11.4 + 4.0 × IM [g]/BSA [m(2)]. • Essential iodine dose at 80-kVp CT was 0.28 gI/kg or 9.6 gI/m(2).
RCT Entities:
OBJECTIVES: To determine the optimal iodine mass (IM) to achieve a 50-HU increase in hepatic attenuation for the detection of liver metastasis based on total body weight (TBW) or body surface area (BSA) at 80-kVp computed tomography (CT) imaging of the liver. METHODS: One-hundred and fifty patients who underwent contrast-enhanced CT at 80-kVp were randomised into three groups: 0.5 gI/kg, 0.4 gI/kg and 0.3 gI/kg. Portal venous phase images were evaluated for hepatic parenchymal enhancement (∆HU) and visualisation of liver metastasis. Iodine mass per BSA (gI/m(2)) calculated in individual patients were evaluated. RESULTS: Mean ∆HU for the 0.5 gI/kg group (84.2 HU) was higher than in the 0.4 gI/kg (66.1 HU) and 0.3 gI/kg (53.7 HU) groups (P < 0.001). Linear correlation equations between ∆HU and IM per TBW or BSA are ∆HU = 7.0 + 153.0 × IM/TBW (r = 0.73, P < 0.001) and ∆HU = 11.4 + 4.0 × IM/BSA (r = 0.75, P < 0.001), respectively. The three groups were comparable for the visualisation of hepatic metastases. CONCLUSIONS: The iodine mass to achieve a 50-HU increase in hepatic attenuation at 80-kVp CT was estimated to be 0.28 gI/kg of body weight or 9.6 gI/m(2) of body surface area. KEY POINTS: • Hepatic enhancement is expressed as ∆HU = 7.0 + 153.0 × IM [g]/TBW [kg]. • Hepatic enhancement is expressed as ∆HU = 11.4 + 4.0 × IM [g]/BSA [m(2)]. • Essential iodine dose at 80-kVp CT was 0.28 gI/kg or 9.6 gI/m(2).
Authors: Mannudeep K Kalra; Michael M Maher; Thomas L Toth; Bernhard Schmidt; Bryan L Westerman; Hugh T Morgan; Sanjay Saini Journal: Radiology Date: 2004-10-21 Impact factor: 11.105
Authors: Kyongtae T Bae; Brian A Seeck; Charles F Hildebolt; Cheng Tao; Fang Zhu; Masayuki Kanematsu; Pamela K Woodard Journal: AJR Am J Roentgenol Date: 2008-03 Impact factor: 3.959
Authors: Daniele Marin; Rendon C Nelson; Sebastian T Schindera; Samuel Richard; Richard S Youngblood; Terry T Yoshizumi; Ehsan Samei Journal: Radiology Date: 2010-01 Impact factor: 11.105
Authors: Bibi Martens; Joris G A Bosschee; Sander M J Van Kuijk; Cécile R L P N Jeukens; Maikel T H Brauer; Joachim E Wildberger; Casper Mihl Journal: PLoS One Date: 2022-04-07 Impact factor: 3.240
Authors: Daniel Overhoff; Gregor Jost; Michael McDermott; Olaf Weber; Hubertus Pietsch; Stefan O Schoenberg; Ulrike Attenberger Journal: Tomography Date: 2021-11-29